New Sorafenib Phase II Clinical Trial OPENS
Dr. Matthias Karajannis, New York University's, Lagone Medical Center just announced that enrollment for the Phase II Study of Sorafenib in Children (and young adults) with recurrent or progressive Low-Grade Astrocytoma (including optic pathway gliomas) is officially OPEN! Three other institutions, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles and Johns Hopkins University are all set to open for enrollment shortly.